Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The revision in the history was updated to v3.6.2, replacing the previous v3.6.0. This indicates a small metadata update to the page's revision record.
    Difference
    0.0%
    Check dated 2026-06-26T19:37:44.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating the study is not seeking participants. A new revision label 'v3.6.0' is added and the previous 'v3.5.5' revision is deleted.
    Difference
    0.1%
    Check dated 2026-06-12T12:17:08.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed from the history.
    Difference
    0.0%
    Check dated 2026-06-05T09:11:02.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision v3.5.4 was added to the history, replacing the previous v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-14T23:08:27.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.3, was added to the history to document an update, replacing the previous v3.5.2. This reflects an administrative update recorded in the page history.
    Difference
    0.0%
    Check dated 2026-04-30T17:38:33.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed on the Record History page, replacing the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:39:49.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.